| 0 |
REACTIVE CAPILLARY ENDOTHELIAL PROLIFERATION |
1 |
0.0182 |
| 1 |
SKIN HYPERPLASIA |
1 |
0.0175 |
| 2 |
LEIOMYOSARCOMA METASTATIC |
1 |
0.0147 |
| 3 |
ENDOCRINE TOXICITY |
1 |
0.0098 |
| 4 |
OXYGEN SATURATION IMMEASURABLE |
1 |
0.0091 |
| 5 |
DERMATOCHALASIS |
1 |
0.0068 |
| 6 |
MUSCULOSKELETAL TOXICITY |
1 |
0.0054 |
| 7 |
URINARY OCCULT BLOOD POSITIVE |
1 |
0.0043 |
| 8 |
THYROIDITIS SUBACUTE |
1 |
0.0034 |
| 9 |
POST PROCEDURAL PNEUMONIA |
1 |
0.0033 |
| 10 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
1 |
0.0026 |
| 11 |
RADIATION OESOPHAGITIS |
1 |
0.0026 |
| 12 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 13 |
TRI-IODOTHYRONINE INCREASED |
1 |
0.0025 |
| 14 |
HAEMANGIOMA OF SKIN |
1 |
0.0023 |
| 15 |
IMMUNE-MEDIATED HYPOPHYSITIS |
1 |
0.0022 |
| 16 |
HYPOPHYSITIS |
3 |
0.0015 |
| 17 |
THYROXINE INCREASED |
1 |
0.0014 |
| 18 |
IMMUNE-MEDIATED MYOCARDITIS |
2 |
0.0012 |
| 19 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 20 |
HYPERPLASIA |
1 |
0.0011 |
| 21 |
OCULAR TOXICITY |
1 |
0.0009 |
| 22 |
MYOCARDIAL INJURY |
1 |
0.0009 |
| 23 |
HYPOTHALAMO-PITUITARY DISORDER |
1 |
0.0007 |
| 24 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 25 |
IMMUNE-MEDIATED ENTEROCOLITIS |
2 |
0.0005 |
| 26 |
OTOTOXICITY |
1 |
0.0005 |
| 27 |
ADENOCARCINOMA OF COLON |
1 |
0.0005 |
| 28 |
MYOCARDITIS |
6 |
0.0005 |
| 29 |
ADRENAL DISORDER |
1 |
0.0005 |
| 30 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 31 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 32 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 33 |
HYPOALBUMINAEMIA |
3 |
0.0004 |
| 34 |
MYASTHENIA GRAVIS |
3 |
0.0004 |
| 35 |
IMMUNE-MEDIATED MYOSITIS |
1 |
0.0004 |
| 36 |
MYELOSUPPRESSION |
13 |
0.0004 |
| 37 |
ANAPHYLACTIC SHOCK |
9 |
0.0003 |
| 38 |
HYPOTHYROIDISM |
10 |
0.0003 |
| 39 |
SKIN INJURY |
1 |
0.0003 |
| 40 |
REGURGITATION |
1 |
0.0003 |
| 41 |
NEUROTOXICITY |
5 |
0.0003 |
| 42 |
PAPULE |
2 |
0.0003 |
| 43 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 44 |
PROTEINURIA |
5 |
0.0003 |
| 45 |
THYROID DISORDER |
4 |
0.0003 |
| 46 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 47 |
HEPATIC FUNCTION ABNORMAL |
9 |
0.0002 |
| 48 |
PNEUMONITIS |
6 |
0.0002 |
| 49 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 50 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
5 |
0.0002 |
| 51 |
HAEMATOTOXICITY |
2 |
0.0002 |
| 52 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 53 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 54 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 55 |
LEUKOPENIA |
10 |
0.0002 |
| 56 |
DERMATITIS EXFOLIATIVE |
1 |
0.0002 |
| 57 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 58 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 59 |
OESOPHAGITIS |
2 |
0.0002 |
| 60 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 61 |
SKIN TOXICITY |
1 |
0.0002 |
| 62 |
GRANULOCYTOPENIA |
1 |
0.0002 |
| 63 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 64 |
SKIN WARM |
1 |
0.0002 |
| 65 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 66 |
LIVER INJURY |
4 |
0.0002 |
| 67 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 68 |
ENTERITIS |
1 |
0.0002 |
| 69 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 70 |
TACHYPNOEA |
2 |
0.0001 |
| 71 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 72 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 73 |
METASTASES TO BONE |
2 |
0.0001 |
| 74 |
EMBOLISM |
1 |
0.0001 |
| 75 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 76 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 77 |
DRUG ERUPTION |
2 |
0.0001 |
| 78 |
CARDIOTOXICITY |
1 |
0.0001 |
| 79 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 80 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 81 |
MYOSITIS |
1 |
0.0001 |
| 82 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 83 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 84 |
DERMATITIS |
2 |
0.0001 |
| 85 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 86 |
NERVE INJURY |
1 |
0.0001 |
| 87 |
HEPATOTOXICITY |
2 |
0.0001 |
| 88 |
THROMBOCYTOPENIA |
10 |
0.0001 |
| 89 |
SPINAL PAIN |
1 |
0.0001 |
| 90 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 91 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 92 |
ILEUS |
1 |
0.0001 |
| 93 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 94 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
| 95 |
SKIN REACTION |
1 |
0.0001 |
| 96 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 97 |
ANAEMIA |
13 |
0.0001 |
| 98 |
LYMPHOMA |
1 |
0.0001 |
| 99 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 100 |
CYSTITIS |
2 |
0.0001 |
| 101 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 102 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 103 |
METASTASES TO LIVER |
1 |
0.0001 |
| 104 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 105 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 106 |
MELAENA |
1 |
0.0000 |
| 107 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 108 |
NEUTROPENIA |
6 |
0.0000 |
| 109 |
SHOCK |
1 |
0.0000 |
| 110 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 111 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 112 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 113 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 114 |
SKIN ULCER |
1 |
0.0000 |
| 115 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 116 |
PANCREATITIS |
2 |
0.0000 |
| 117 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 118 |
HEPATIC FAILURE |
1 |
0.0000 |
| 119 |
HYPERHIDROSIS |
4 |
0.0000 |
| 120 |
LIP SWELLING |
1 |
0.0000 |
| 121 |
FLUSHING |
3 |
0.0000 |
| 122 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 123 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 124 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 125 |
COLITIS |
1 |
0.0000 |
| 126 |
RASH |
11 |
0.0000 |
| 127 |
CARDIAC FAILURE |
2 |
0.0000 |
| 128 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 129 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 130 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 131 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 132 |
HYPOKALAEMIA |
1 |
0.0000 |
| 133 |
DECREASED APPETITE |
5 |
0.0000 |
| 134 |
ARRHYTHMIA |
1 |
0.0000 |
| 135 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 136 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 137 |
PYREXIA |
7 |
0.0000 |
| 138 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 139 |
HYPERTENSION |
4 |
0.0000 |
| 140 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 141 |
RASH PRURITIC |
1 |
0.0000 |
| 142 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 143 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 144 |
PRURITUS |
7 |
0.0000 |
| 145 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 146 |
HYPONATRAEMIA |
1 |
0.0000 |
| 147 |
HERPES ZOSTER |
1 |
0.0000 |
| 148 |
DYSPHONIA |
1 |
0.0000 |
| 149 |
PALPITATIONS |
2 |
0.0000 |
| 150 |
VOMITING |
8 |
0.0000 |
| 151 |
IRRITABILITY |
1 |
0.0000 |
| 152 |
STOMATITIS |
1 |
0.0000 |
| 153 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 154 |
DISCOMFORT |
1 |
0.0000 |
| 155 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 156 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 157 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 158 |
ERYTHEMA |
3 |
0.0000 |
| 159 |
DIARRHOEA |
9 |
0.0000 |
| 160 |
CONSTIPATION |
3 |
0.0000 |
| 161 |
ASTHENIA |
5 |
0.0000 |
| 162 |
DIABETES MELLITUS |
1 |
0.0000 |
| 163 |
NAUSEA |
10 |
0.0000 |
| 164 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 165 |
PNEUMONIA |
4 |
0.0000 |
| 166 |
TREATMENT FAILURE |
1 |
0.0000 |
| 167 |
MYALGIA |
2 |
0.0000 |
| 168 |
TACHYCARDIA |
1 |
0.0000 |
| 169 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 170 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 171 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 172 |
HEART RATE INCREASED |
1 |
0.0000 |
| 173 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 174 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 175 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 176 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 177 |
FATIGUE |
6 |
0.0000 |
| 178 |
RENAL FAILURE |
1 |
0.0000 |
| 179 |
VISION BLURRED |
1 |
0.0000 |
| 180 |
HYPOAESTHESIA |
1 |
0.0000 |
| 181 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 182 |
URTICARIA |
1 |
0.0000 |
| 183 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 184 |
OFF LABEL USE |
5 |
0.0000 |
| 185 |
DYSPNOEA |
3 |
0.0000 |
| 186 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 187 |
HYPOTENSION |
1 |
0.0000 |
| 188 |
DIZZINESS |
2 |
0.0000 |
| 189 |
WEIGHT DECREASED |
1 |
0.0000 |
| 190 |
DEATH |
3 |
0.0000 |
| 191 |
ARTHRALGIA |
1 |
0.0000 |
| 192 |
DRUG INEFFECTIVE |
2 |
0.0000 |